News Viral Safety Expert, Audrey Brussel, joins PathoQuest Pour la version en français de ce communiqué de presse : cliquez ici Audrey Brussel brings her industrial expertise to support the development of added-value services for the quality control of biologics...
News PathoQuest Announces Appointment of Laurent Lafferrere as Chief Operating Officer PARIS, FRANCE, April 27, 2020 – PathoQuest,a leading genomic expert in clinical diagnostics and biologics testing applications with innovative next-generation sequencing (NGS)...
Other Transgene chooses PathoQuest innovative NGS-based safety release test for TG4050 phase I clinical trial targeting patients with head-neck and ovarian cancers and for Invir.IO™ a platform for recombinant viral vector manufacturing. Return to the list of...
Press Release PathoQuest CEO Jean-François Brepson discusses “NGS and New Frontiers in Infectious Disease” during new Illumina Genomics podcast In a new Illumina Genomics Podcast (Episode 53), Jean-François Brepson discusses the company’s vision of the impact of NGS...
Press Release PathoQuest named 32nd most inventive start-up in France 100brevets.tech – Inventors of the French Tech Awards – has ranked PathoQuest as the 32nd most inventive start-up based in France and the 7th ranked MedTech company. See the list as reported...
News PathoQuest Announces Appointment of Patrick Court as Chief Financial Officer PARIS, FRANCE, July 22, 2019 – PathoQuest, a genomic expert dedicated to the microbiology testing market, the leader in clinical diagnostics and biologics testing applications, today...
By closing this message or navigating within the website, you consent to our use of cookies on this device in accordance with our cookie policy unless you have disabled them.Ok